Anti-Obesity Prescription Drugs Market - Detailed Analysis and Forecast by 2024

1
Anti-Obesity Prescription Drugs Market Global
Industry Analysis, Trends, Market Size and
Forecasts up to 2024
2
The report on Anti-Obesity Prescription Drugs
Market by drug class (orlistat, phentermine and
topiramate, bupropion and naltrexone, lorcaserin,
liraglutide), by distribution channel (retail
pharmacy, hospital pharmacy and online pharmacy),
and byage group (pediatric and adult) trends
analysis and forecasts up to 2024 studies the
market sizes, key trends and opportunities in the
main geographies such as North America, Europe,
Asia-Pacific, Rest of the World. According to the
report the Global Anti-Obesity Prescription Drugs
Market is projected to grow at a CAGR of 4.97 in
terms of value over the period of 2018-2024. The
growth in the world market is primarily driven by
significant contribution by North America
(Leading region) region to this market. The
report identified that North America
dominated the global anti-obesity
prescription drugs market over the last
couple of years, while emerging markets of
Asia-Pacific and Latin America are anticipated to
contribute significantly to the growth in the
anti-obesity prescription drugs market
worldwide. The global anti-obesity
prescription drugs market is driven by
factors such as rising obesity concerns,
substantial rise in obesity related chronic
diseases and growing workload. Moreover, the
growth matrix presented by Infinium Global
Research identifies the key investment markets in
the near future, this will not only help the
companies to understand the competitive position
in the global anti-obesity prescription drugs
market but also make strategic decisions to
capture the most lucrative markets in the near
future. The market size is presented in terms of
value for the historic year 2016 and estimated
for forecast period of 2018-2024. About Infinium
Global Research Infinium Global Research is a
business intelligence company that provides its
clients with market information services,
solutions, and reports. The intelligence reports
include qualitative as well as quantitative
information, which are blended using forecasting
models in order to project future market demand.
Our panels of Subject Matter Experts (SMEs),
Analysts, and Consultants use numerous data
gathering tools in order to provide you with
detailed information on the market as well as a
preview of its projected growth. Our repository
includes the largest and most credible databases,
through which we determine various qualitative
and quantitative parameters of the market to
provide you with an in-depth business
intelligence report. Infinium Global Research
reports and consulting services cover
numerous sectors, which include healthcare,
chemicals, materials, energy, packaged goods,
food and beverages, technology, and
communications. These reports provide readers
with market insights and detailed analysis of
market segments to possible micro levels. Our
reports, with stratified research methodology and
wider scope of analysis, provide clients with
crucial insights and information to meet their
every requirement.
3

• Get Free Sample Pages of this Premium Report
  https//www.infiniumglobalresearch.com/Reports/Mak
  eSampleRequest/1127 Table of Contents-
• Preface
• Report Description
• Research Methods
• Research Approaches
• Executive Summary
• Global Anti-obesity Prescription Drugs Market
  Overview
• Introduction
• Market Dynamics
• Drivers

3.5. Competitive Landscape in the Global
Anti-obesity Prescription Drugs Market
4

• Global Anti-obesity Prescription Drugs Market by
  Drug Class
• Orlistat
• Phentermine and Topiramate
• Bupropion and Naltrexone
• Lorcaserin
• Liraglutide
• Global Anti-obesity Prescription Drugs Market by
  Distribution Channel
• Retail Pharmacy
• Hospital Pharmacy
• Online Pharmacy

7.1.1. North America Anti-obesity Prescription
Drugs Market by Drug Class
5

• North America Anti-obesity Prescription Drugs
  Market by Distribution Channel
• North America Anti-obesity Prescription Drugs
  Market by Age Group
• North America Anti-obesity Prescription Drugs
  Market by Country
• Europe
• Europe Anti-obesity Prescription Drugs Market by
  Drug Class
• Europe Anti-obesity Prescription Drugs Market by
  Distribution Channel
• Europe Anti-obesity Prescription Drugs Market by
  Age Group
• Europe Anti-obesity Prescription Drugs Market by
  Country
• Asia-Pacific
• Asia-Pacific Anti-obesity Prescription Drugs
  Market by Drug Class

7.4.2. RoW Anti-obesity Prescription Drugs Market
by Distribution Channel
6

• RoW Anti-obesity Prescription Drugs Market by Age
  Group
• RoW Anti-obesity Prescription Drugs Market by
  Sub-region
• Company Covered
• F Hoffmann La Roche Ltd
• Orexigen Therapeutics, Inc
• Novo Nordisk A/s
• Arena Pharmaceuticals, Inc
• Glaxosmithkline
• Vivus, Inc
• Boehringer Ingelheim